CliffBio
small molecule

MYDCOMBI

PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE

Loss of exclusivityJuly 2031latest FDA-listed patent expiry
CompanyEyenovia →View the full company profile on CliffBio

Drug detail

Brand nameMYDCOMBI
Active ingredientPHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE
Strength2.5%;1%
Dosage formSPRAY, METERED
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 2023
Marketing statusDISCN

Listed patents

PatentExpiresType
11398306July 2031use U-3685
10839960July 2031use U-3685
11839487July 2031use U-3685

Regulatory exclusivity

CodeExpires
NPMay 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MYDCOMBI patent cliff — loss of exclusivity July 2031 | CliffBio